Detalles de la búsqueda
1.
The Inflammatory Bowel Disease-Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version.
J Clin Med
; 12(8)2023 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37109360
2.
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.
Eur J Gastroenterol Hepatol
; 33(1S Suppl 1): e810-e817, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402469
3.
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
Eur J Gastroenterol Hepatol
; 29(9): 1054-1058, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28628496
4.
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Inflamm Bowel Dis
; 15(3): 375-82, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19009634
5.
The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease.
J Crohns Colitis
; 1(1): 28-34, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172181
6.
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Am J Gastroenterol
; 99(6): 1122-8, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15180735
7.
Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Clin Gastroenterol Hepatol
; 1(2): 122-8, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15017504
Resultados
1 -
7
de 7
1
Próxima >
>>